# Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®

> **NCT01540734** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Marketed paracetamol
- **DRUG:** Experimental paracetamol formulation

## Key facts

- **NCT ID:** NCT01540734
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01540734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01540734, "Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01540734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*